Published in TB and Outbreaks Week, April 25th, 2000
In the April 6, 2000, issue of the British scientific journal Nature, a team of scientists from the University of Wisconsin-Madison report the design, synthesis, and evaluation of a new type of molecule that exhibits a wide spectrum of antimicrobial activity, including against two species of bacteria that are resistant to common antibiotic drugs.
The work is important because it demonstrates the feasibility of developing a new class of antibiotics that can potentially overcome the growing resistance of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.